DOCSLIB.ORG

Such Written Comments Upon the Ap Plicant, the Secretary of Transporta Tion, the Attorney General and All Par Ties of Reco

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Such Written Comments Upon the Ap Plicant, the Secretary of Transporta Tion, the Attorney General and All Par Ties of Reco NOTICES 38163 such written comments upon the ap­ be used by Soo Line only for overhead City, Hinckley, and Sandstone. The plicant, the Secretary of Transporta­ traffic. Soo Line, would not serve any transaction proposed by Soo Line is tion, the Attorney General and all par­ local industries located on^the line be­ subject to the execution of an appro­ ties of record in Finance Docket No. tween Schley (Soo Junction), Minn., 28583 (Sub-1F). priate agreement between Soo Line and Superior, Wis. and BN. This application has been ac­ By the Commission. Interested persons may participate formally in this proceeding by submit­ cepted and assigned Finance Docket H. G. H omme, Jr., ting written comments in regard to No. 28583 (Sub-No. 6F). Acting Secretary. the application. Such submissions This application has been filed in re­ [FR Doc. 78-24076 Filed 8-24-78; 8:45 am] shall indicate the proceeding designa­ sponse to Finance Docket No. 28583 tion (F.D. No. 28583 (Sub-5F)), and the (Sub-No. IF), Burlington Northern, original and two copies thereof shall Inc.—control and merger—St. Louis- [7035-01] be filed with the Secretary, Interstate San Francisco Railway Co. Soo Line is Commerce Commission, Washington, seeking the imposition of these track­ [Finance Docket No. 28583 (Sub-5F)] D.C. 2Q423, not later than October 10, age rights as a condition in the event 1978. Such written comments shall in­ the BN-Frisco merger is approved by SOO LINE RAILROAD CO. clude the following: the person’s posi­ tion, e.g., party protestant or party in the Commission in order to offset pro- Trackage Rights Over Burlington Northern, Inc., jeted gross revenue losses. This pro­ Between Schley (Soo Junction), Minn, and support, regarding the proposed trans­ Superior, Wis. action; and specific reasons why ap­ ceeding will be consolidated with Fi­ proval would or would not be in the nance Docket No. 28583 (Sub-No. IF). Soo Line Railroad Co. (Soo Line), a public interest. This proceeding has Soo Line operates approximately Minnesota corporation, with general been set for oral hearing. Additionally, 4,588 miles of railroad in the States of offices at 804 Soo Line Building, P.O. interested persons who do not intend Illinois, Michigan, Minnesota, Mon­ Box 530, Minneapolis, Minn. 55440 to participate formally in a proceeding tana, North Dakota, South Dakota, represented by F. W. Crouch, vice but who desire to comment thereon, and Wisconsin. Canadian Pacific Lim­ president and general counsel, and may file such statements and informa­ Robert G. Gehrz, general solicitor, ited (CP) controls Soo Line and had tion as they may desire, subject to the the right to vote 56.23 percent of Soo each of the foregoing address, hereby filing and service requirements speci­ gives notice that on the 26th day of fied herein. Persons submitting writ­ Line’s common stock, as of March 10, July 1978, it filed with the Interstate ten comments to the Commission 1978. Soo Line is operated indepen­ Commerce Commission at Washing­ shall, at the same time, serve copies of dently of CP. ton, D.C. an application under section such written comments upon appli­ The trackage involved is approxi­ 5(2) of the Interstate Commerce Act cant, the Secretary of Transportation, mately 126.4 miles in length and would for a decision approving and authoriz­ Attorney General, and all parties of be used by Soo Line only for overhead ing the grant of trackage rights to record in Finance Docket No. 28583 traffic. Soo Line would not serve any permit Soo Line to operate its own lo­ (Sub-1F). local industries located on the line be­ comotives, cars and trains with its own By the Commission. tween Bald Eagle, Minn., and Superi­ crews for “bridge” purposes, only be­ or, Wis. tween Schley (Soo Junction), Minn., H. G. H omme, Jr., and Superior, Wis., over trackage of Acting Secretary. Interested persons may participate Burlington Northern, Inc. (BN), and formally in this proceeding by submit­ to construct an appropriate connec­ [FR Doc. 78-24077 Filed 8-24-78; 8:45 am] ting written Comments in regard to tion at Superior, Wis. The transaction the application. Such submissions proposed by Soo Line is subject to the [7035-01] shall indicate the proceeding designa­ execution of an appropriate agree­ tion (F.D. No. 28583 (Sub.-No. 6F)), ment between Soo Line and BN. This [Finance Docket No. 28583 (Sub-No. 6F)] and the original and two copies there­ application has been accepted and as­ of shall be filed with the Secretary, In­ signed Finance Docket No. 28583 (Sub- SOO LINE RAILROAD CO. 5F). terstate Commerce Commission, This application has been filed in re­ Trackage Rights Over Burlington Northern, Inc., Washington, D.C. 20423, not later sponse to Finance Docket No. 28583 Between Bald Eagle, Minn., and Superior, Wis. than October 10, 1978. Such written (Sub-1F), Burlington Northern, Inc.— Soo Line Railroad Co. (Soo Line), a comments shall include the following: control and merger—St. Louis-San Minnesota corporation, with general The person’s position, e.g., party prot- Francisco Railway, Co. Soo Line is offices at 804 Soo Line Building, P.O. estant or party in support, regarding seeking the imposition of these track­ Box 530, Minneapolis, Minn. 55440. the proposed transaction, and specific age rights as a condition in the event Represented by F. W. Crouch, Vice reasons why approval would or would the BN-Frisco merger is approved by President and General Counsel, and not be in the public interest. This pro­ the Commission in order to offset pro­ Robert G. Gehrz, General Solicitor, ceeding has been set for oral hearing. jected gross revenue losses. This pro­ each of the foregoing address, hereby Additionally, interested persons who ceeding will be consolidated with Fi­ gives notice that on the 26th day of do not intend to participate formally nance Docket No. 28583 (Sub-1F). July 1978, it filed with the Interstate in a proceeding, but who desire to Soo Line operates approximately Commerce Commission at Washing­ 4,588 miles of railroad in the States of comment thereon, may file such state­ ton, D.C,, an application under section ments and information as they may Illinois, Michigan, Minnesota, Mon­ 5(2) of the Interstate Commerce Act tana, North Dakota, South Dakota, for a decision approving and authoriz­ desire, subject to the filing and service and Wisconsin. Canadian Pacific Lim­ ing the grant of trackage rights to requirements specified herein. Persons ited (CP) controls Soo Line and had permit Soo Line to operate its own lo­ submitting written comments to the the right to vote 56.23 percent of Soo comotives, cars and trains with its own Commission shall, at the same time, Line’s common stock, as of March 10, crews for “bridge” purposes only be­ serve copies of such written comments 1978. Soo Line is operated indepen­ tween Bald Eagle, Minn., and Superi­ upon the Applicant, the Secretary of dently of CP. or, Wis., over trackage of Burlington Transportation, the Attorney General, The trackage involved is approxi­ Northern, Inc. (BN), via White Bear and all parties of record in Finance mately 146.2 miles in length and would Lake, Forest Lake, Rush City, Pine Docket No. 28583 (Sub-No. IF). FEDERAL REGISTER, VOL. 43, NO. 166— FRIDAY, AUGUST 25, 1978 38164 NOTICES By the. Commission. This application has been filed in re­ ceivers it currently serves through re­ sponse to Finance Docket No. 28583 ciprocal switching arrangements. H. G. H omme, Jr., Acting Secretary. (Sub-No. IF), Burlington Northern, Interested persons may participate Inc.—control and merger—St. Louis- formally in a proceeding by submitting [FR Doc. 78-24078 Filed 8-24-78; 8:45 am] San Francisco Railway Co. SP is seek­ written comments in regard to the ap­ ing the imposition of these trackage plication. Such submissions shall indi­ rights as a condition in the event the cate the proceeding designation (F.D. [7035-01] BN-Frisco merger is approved by the No. 28583 (Sub-No. 18F)), and the Commission in order to offset project­ original and two copies thereof shall [Finance Docket No. 28583 (Sub-No. 18F)] ed gross revenue losses. This proceed­ be filed with the Secretary, Interstate ing will be consolidated with Finance Commerce Commission, Washington, SOUTHERN PACIFIC TRANSPORTATION CO. Docket No. 28583 (Sub-No. IF). D.C. 20423, not later than October 10, SP and its subsidiaries operate ap­ 1978. Such written comments shall in­ Trackage Rights Over Burlington Northern, Inc., clude the following: the persons posi­ and the Union Pacific Railroad Co. Between proximately 13,356 miles of railroad in the Connection of BN and the Portland Ter­ the States of Arizona, Arkansas, Cali­ tion, e.g., party protestant or party in minal Railroad Co. and (1) Trackage Serving fornia, Illinois, Louisiana, Missouri, support, regarding the proposed trans­ North Rivergate and (2) the Barnes Yard of Nevada, New Mexico, Oregon, Tennes­ actions; and specific reasons why ap­ see, Texas, and Utah. The Southern proval would or would not be in the Union Pacific Railroad Co. Pacific Co. owes 100 percent of the public interest. This proceeding has Southern Pacific Transportation Co. stock of SP. been set for oral hearing. Additionally, (SP), One Market Plaza, San Francis­ The trackage involved is approxi­ interested persons who do not intend co, Calif. 94105, represented by mately 16.3 miles in length. SP would to participate formally in a proceed­ Charles W. Burkett, general solicitor, use the line to directly serve the Ri- ing, but who desire to comment there­ of the same address, hereby gives vergate industrial area.
Load more

Recommended publications
  • May 23, 2007 Office of Pesticide Programs
    May 23, 2007 Office of Pesticide Programs (OPP) Regulatory Public Docket (7502P) Environmental Protection Agency 1200 Pennsylvania Ave., NW Washington, DC 20460-0001 RE: Insect Repellent-Sunscreen Combination Products [EPA-HQ-OPP-2007-0087] Beyond Pesticides appreciates the prudent contemplation of insect repellent-sunscreen combination products EPA proposed in the reregistration eligibility decision (RED) for N,N-diethyl-meta-toluamide (DEET). We also appreciate this opportunity to share our concerns over these products. Beyond Pesticides interest in this issue lies in our effort to restrict pesticide use in a manner that protects public health and the environment, and to advance alternatives that eliminate dependency on toxic chemicals. We oppose the reregistration of all DEET-sunscreen combination products for the following reasons: 1. DEET exposure can result in negative health effects. As the agency notes, the registration of DEET is unusual in that it is one of few residential-use pesticides that is applied directly to the skin. The result is that the public is being exposed to a pesticide that has the ability to cause in lab animals increased fetal loss, bone and skeleton abnormalities in the offspring of rabbits, birth defects in birds, reduction in size of the testes and degeneration, and has produced abnormal sperm with reduced motility. Additionally, the public is directly applying a chemical to their skin that is demonstrated to cross the placenta and move into fetal blood in humans, has the ability to cause mutagenicity and oxidative stress, can decrease sensory and motor skills, causes skin irritation and kills brain cells.1 2. Sunscreen exposure can result in negative health effects.
    [Show full text]
  • A Thesis Entitled Evaluating UVB and UVA Boosting Technologies For
    A Thesis entitled Evaluating UVB and UVA Boosting Technologies for Chemical and Physical Sunscreens by An Ngoc Hiep Huynh Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Science Degree in Pharmaceutical Sciences Industrial Pharmacy ___________________________________________ Gabriella Baki, Ph.D., Committee Chair ___________________________________________ Jerry Nesamony, Ph.D., Committee Member ___________________________________________ Matthew W. Liberatore, Ph.D., Committee Member ___________________________________________ Dr. Amanda C. Bryant-Friedrich, Dean College of Graduate Studies The University of Toledo May 2020 Copyright 2020 An Ngoc Hiep Huynh This document is copyrighted material. Under copyright law, no parts of this document may be reproduced without the expressed permission of the author. An Abstract of Evaluating UVB and UVA Boosting Technologies for Chemical and Physical Sunscreens by An Ngoc Hiep Huynh Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Science Degree in Pharmaceutical Sciences Industrial Pharmacy The University of Toledo May 2020 There are currently 14 organic and 2 inorganic UV filters approved in the United States. Due to coral reef safety concerns, octinoxate and oxybenzone have been banned in Hawaii, Key West, FL and the US Virgin Islands; and octocrylene is also being studied for its potential impact on coral reef safety, leaving 11 organic UV filters as viable options for sunscreen manufacturers – with limitations on their combination. Since consumers are always looking for sunscreens with high SPF and broad-spectrum protection, the need for UVB and UVA protection boosting technologies is greater than ever. In a preliminary study, about two dozen emollients were scanned for their SPF boosting capability with selected organic UV filters.
    [Show full text]
  • Sun Protection, Sunscreens and Vitamin D
    SunSun protection,protection, sunscreenssunscreens andand VitaminVitamin DD GPGP NationalNational ConferenceConference RotoruaRotorua EnergyEnergy EventsEvents CentreCentre JuneJune 20092009 Dr. Louise Reiche Dermatologist New Zealand Dermatological Society Incorporated MelanomaMelanoma SkinSkin cancercancer andand sunlightsunlight Exposure to UVR causes > 90% of skin cancers Skin cancer is commonest cancer in NZ >50,000 new cases per year ~300 deaths per year ~$33.4 NZ million per year International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risks to humans. Solar ultraviolet radiation. Lyon: International Agency for Research on Cancer, 1992. Armstrong BK. How sun exposure causes skin cancer. In: Hill D, Elwood JM, English DR, Eds. Prevention of Skin Cancer. Dordrecht: Kluwer Academic Publishers, 2004. O’Dea D. The Costs of Skin Cancer to New Zealand. Wellington: Cancer Society of New Zealand, 2000. New Zealand Health Information Service. Cancer, New Registrations and Deaths. Wellington: New Zealand Health Information Service, 2004. MelanomaMelanoma 1842 new cases in 2002 328 directly attributable to severe sunburn (Sneyd and Cox 2006) Authors recommended, “to reduce burden of melanoma in NZ, need to prevent excessive sun exposure and (facilitate) early diagnosis” Whilst cancer overall is rare in adolescence, melanoma was commonest cancer MelanomaMelanoma NZ incidence and death rate among world highest 56.2/100,000 in European population of Auckland highest reported worldwide men
    [Show full text]
  • Sunscreen Faqs
    Sunscreen FAQs What type of sunscreen should I use? There are two main types of sunscreen ingredients: physical sun blockers and chemical sunscreens. Physical sunscreens prevent ultraviolet light from reaching your skin, and contain either zinc oxide or titanium dioxide. Physical sunscreens protect against UVA and UVB damage. Physical sunscreens are preferred for patients with sensitive skin or children. Chemical sunscreens rely on an interaction between the sun and the chemical to protect your skin. Examples of such chemicals are avobenzone, octinoxate, homosalate, padimate O, and many others. Chemical sunscreens can protect against UVA, UVB, or both types of damage, depending on which ingredient is used. Read the label to ensure coverage for both UVA and UVB exposure. There are new ingredients being developed that take chemical sunscreens and stabilize them to prolong their activity (i.e., Helioplex, Mexoryl). Does the SPF really matter? In laboratory testing, there are minor differences between SPF 15 and SPF 30 or greater products. However, that data is based on using 1 oz. (30 gm.) of sunscreen for each full body application (the size of a shot glass). Most people use far less in real-life settings. For that reason, we recommend an SPF of at least 30. It is common to find good sunscreens with SPF ranging from 45-70. To maintain protection, reapply sunscreen every 1-3 hours, depending on sweating, water exposure, and sun intensity. Is sunscreen alone enough to protect my skin in the sun? In some cases, yes. However, if you are in the sun for longer periods on a regular basis (such as gardening, golfing, boating, sports), it may be better to add sun protective clothing or habits.
    [Show full text]
  • FDA Proposes Sunscreen Regulation Changes February 2019
    FDA Proposes Sunscreen Regulation Changes February 2019 The U.S. Food and Drug Administration (FDA) regulates sunscreens to ensure they meet safety and eectiveness standards. To improve the quality, safety, and eectiveness of sunscreens, FDA issued a proposed rule that describes updated proposed requirements for sunscreens. Given the recognized public health benets of sunscreen use, Americans should continue to use broad spectrum sunscreen with SPF 15 or higher with other sun protective measures as this important rulemaking eort moves forward. Highlights of FDA’s Proposals Sunscreen active ingredient safety and eectiveness Two ingredients (zinc oxide and titanium dioxide) are proposed to be safe and eective for sunscreen use and two (aminobenzoic acid (PABA) and trolamine salicylate) are 1 proposed as not safe and eective for sunscreen use. FDA proposes that it needs more safety information for the remaining 12 sunscreen ingredients (cinoxate, dioxybenzone, ensulizole, homosalate, meradimate, octinoxate, octisalate, octocrylene, padimate O, sulisobenzone, oxybenzone, avobenzone). New proposed sun protection factor Sunscreen dosage forms (SPF) and broad spectrum Sunscreen sprays, oils, lotions, creams, gels, butters, pastes, ointments, and sticks are requirements 2 proposed as safe and eective. FDA 3 • Raise the maximum proposed labeled SPF proposes that it needs more data for from SPF 50+ to SPF 60+ sunscreen powders. • Require any sunscreen SPF 15 or higher to be broad spectrum • Require for all broad spectrum products SPF 15 and above, as SPF increases, broad spectrum protection increases New proposed label requirements • Include alphabetical listing of active ingredients on the front panel • Require sunscreens with SPF below 15 to include “See Skin Cancer/Skin Aging alert” on the front panel 4 • Require font and placement changes to ensure SPF, broad spectrum, and water resistance statements stand out Sunscreen-insect repellent combination 5 products proposed not safe and eective www.fda.gov.
    [Show full text]
  • Chemical UVR Absorbers
    Chemical UVR Absorbers The names given in bold and used Diisopropyl methyl cinnamate Glyceryl ethyihexanoate dimethoxy- throughout this handbook are those of Empirical formula: cinnamate the International Nomenclature of C 6H22O2 Chemical names. Cosmetic Ingredients. Glyceryl octanoate dimethoxycinnamate; Chemical names: 2-propenoic acid, 3-(4-methoxyphenyl)-, 2-Propenoic acid, 3-12,4bis(1 diester with 1 ,3-dihydroxy-2-(2-ethyl-1 - methylethyphenyl-methyl ester; 2,5- oxohexyl)oxypropane diisopropyl methyl cinnamate _ lsoamyl-para-methoxycinnamate Ethyihexyl methoxycinnamate Empirical formula: Empirical formula: C151-12003 C 8H26O3 Chemical names: Cinnamates Chemical names: Amyl4-methoxycinnamate; isopentyl-4- 2-Ethylhexyl-4-methoxycin nam ate; methoxycinnamate; isopenlyl-para- Cinoxate 2-ethyl-hexyl-para-methoxycinnamate; methoxy-cinnamate; 3-(4-methoxyphenyl)- Empirical formula: para-methoxycinnamic acid, 2-ethylhexyl 2-propenoic acid, isopentyl ester Ci4HieO4 ester; 3-(4-methoxyphenyl)-2-propenoic acid, 2-ethylhexyl ester; octinoxate; octyl Trade names: Chemical names: methoxycinnamate; 2-propenoic acid, 3- Neo Heliopan type E 1000; Solarum AMC 2- Ethoxyothyl-para-methoxyci n nam ate; (4-methoxyphenyl)-2-ethylhexyl ester 2-propenoic acid, 3-(4-methoxyphery- para-A minobenzoic acids (PA BAs) 2-ethoxyethyl ester; 2-ethoxyethyl-4- Trade names: methoxycinnamate AEC Octyl Methoxycinnamate; Escalol Amyl dimethyl FABA 557; Eusolex 2292; Heliosol 3; Empirical formula: Trade names: Jeescreen OMC; Katoscreen OMC; Nec C14H21 NO2 Giv Tan F; Phiasol
    [Show full text]
  • Sunscreen Alternatives Sunscreen Alternatives
    Sunscreen Alternatives We all know that the sun can be damaging in many ways, but most sunscreens on the market have some questionable, if not dangerous, ingredients. Here are a few ways to play it safe in the sun without putting your health at risk. 1. Common Sense We all know it but often forget: Avoid midday (10 am-2 pm) sun as much as possible, stay in the shade when possible, wear sunglasses and sun hats, don’t stay out exposed for too long. 2. Cover Up! For short periods, especially early or late in the day, sunscreen may not be necessary. In fact, a little exposure every day is vital to keep our Vitamin D levels up! Instead cover the skin with lightweight, tightly woven clothing, and protect your face with a hat. Babies under 6 months especially need to be covered up, since they don’t yet have the protection of melanin. 3. Be a Label Reader Not all sunscreens are created equal. The “worst” chemicals to avoid include Oxybenzone and PABA/Padimate O. Some active ingredients that have been found less toxic include Titanium Dioxide and Zinc Oxide. 4. CaliCaliforniafornia Baby This very eco-friendly company makes three of the top ten sunscreens on Environmental Working Group’s “Low Health Hazard/Low Sun Hazard/Most Effective” list: the SPF 30+ No Fragrance Sunblock Stick, the SPF 30+ Everyday Sunblock Stick, and the SPF 30+ Everyday Lotion. They are widely available and reasonably priced. 5. Homemade There are many recipes out there for DIY sunscreen. Here’s one to try: In a double boiler over medium heat, mix 2 ½ oz sesame oil, 1 ½ oz coconut oil, and 1 ½ oz beeswax.
    [Show full text]
  • Annex VI, Last Update: 02/08/2021
    File creation date: 03/10/2021 Annex VI, Last update: 22/09/2021 LIST OF UV FILTERS ALLOWED IN COSMETIC PRODUCTS Substance identification Conditions Wording of Reference Maximum conditions of Product Type, concentration Update date number Chemical name / INN / XAN Name of Common Ingredients Glossary CAS Number EC Number Other use and body parts in ready for use warnings preparation 2 N,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl CAMPHOR BENZALKONIUM 52793-97-2 258-190-8 6% 15/10/2010 ) anilinium methyl sulphate METHOSULFATE 3 Benzoic acid, 2-hydroxy-, HOMOSALATE 118-56-9 204-260-8 10% 02/08/2021 3,3,5-trimethylcyclohexyl ester / Homosalate 4 2-Hydroxy-4-methoxybenzophenone / BENZOPHENONE-3 131-57-7 205-031-5 6% Reg (EU) Not more than Contains 02/08/2021 Oxybenzone 2017/238 of 10 0,5 % to protect Benzophenone-3 February 2017- product (1) date of formulation application from September 2017 6 2-Phenylbenzimidazole-5-sulphonic acid and its PHENYLBENZIMIDAZOLE SULFONIC 27503-81-7 248-502-0 8%(as acid) 08/03/2011 potassium, sodium and triethanolamine salts / ACID Ensulizole 7 3,3'-(1,4-Phenylenedimethylene) bis TEREPHTHALYLIDENE DICAMPHOR 92761-26-7 / 410-960-6 / - 10%(as acid) 26/10/2010 (7,7-dimethyl-2-oxobicyclo-[2.2.1] SULFONIC ACID 90457-82-2 hept-1-ylmethanesulfonic acid) and its salts / Ecamsule 8 1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl) BUTYL 70356-09-1 274-581-6 5% 15/10/2010 propane-1,3-dione / Avobenzone METHOXYDIBENZOYLMETHANE 9 alpha-(2-Oxoborn-3-ylidene)toluene-4-sulphoni BENZYLIDENE CAMPHOR SULFONIC 56039-58-8 - 6%(as acid)
    [Show full text]
  • Should a Toxicological Risk Assessment of Ubiquitous Chemicals Be Done Using Data from Only One Source of Exposure?
    Mini Review Open Acc J of Toxicol Volume 4 Issue 2 - January 2020 Copyright © All rights are reserved by Di Nardo JC DOI: 10.19080/OAJT.2020.04.555633 Should a Toxicological Risk Assessment of Ubiquitous Chemicals Be Done Using Data from Only One Source of Exposure? Di Nardo JC1* and CA Downs2 1Retired Toxicologist, Vesuvius, USA 2Executive Director, Haereticus Environmental Laboratory, Clifford, USA Submission: January 09, 2020; Published: January 23, 2020 *Corresponding author: Di Nardo JC, Retired Toxicologist, Vesuvius, USA Keywords: Toxicological; Chemicals; Dioxybenzone; Octocrylene; Oxybenzone; Sulisobenzone Introduction consumers to believe that there is no further risk associated with the After much discussion and petitioning by several individuals, chemical. non-governmental organizations and scientists alike, the Food & Drug Administration (FDA) re-opened the sunscreen drug monograph Data on February 26, 2019 to review the safety of sunscreen actives In October of 2018 the Food & Drug Administration (FDA) banned considered Generally Recognized as Safe and Effective (GRASE) the chemical benzophenone from use in foods and/or in plastic food since 1978 [1]. After their review, the FDA concluded that the public wraps [3], because it was found to cause cancer in rodents according to a study conducted by the National Institute of Environmental safety of a dozen drug actives currently in use (several of which record “does not” currently contain sufficient data to support the Health Sciences in May 2007 [3]. In June 2012 the state of California are benzophenone based chemicals - avobenzone, dioxybenzone, added benzophenone to their Proposition 65 list recognizing it as octocrylene, oxybenzone and sulisobenzone) and, therefore, are a carcinogen and came to an agreement that a sunscreen product requesting industry to provide additional data (mainly toxicokinetics, should not contain any more that 50 parts per million [4].
    [Show full text]
  • United States Patent (19) 11 Patent Number: 6,086,858 Mceleney Et Al
    US006086858A United States Patent (19) 11 Patent Number: 6,086,858 McEleney et al. (45) Date of Patent: *Jul. 11, 2000 54). COLORED FORMULATIONS FOR 4,818,491 4/1989 Fariss. APPLICATION TO HUMAN SKIN 4.954,544 9/1990 Chandaria. 5,426.210 6/1995 Kato et al.. 75 Inventors: John McEleney, Newton; Wende SS 8.1. R el, Restry BMS Curtis A. Vock, 5,562,8962- - -2 10/1996 Repperepper et al..al. s 5,567,420 10/1996 McEleney et al. ....................... 424/60 5,609,852 3/1997 Galley et al.. 73 Assignee: IPA, LLC, Forth Worth, Tex. 5,753,210 5/1998 McEleney et al. ....................... 424/59 c: 5,955,062 9/1999 McEleney et al. ... ... 424/59 * Notice: This patent is Subject to a terminal dis- 5,958,383 9/1999 McEleney et al. ....................... 424/59 CC. OTHER PUBLICATIONS 21 Appl. No.: 09/333,088 Deposition Transcript of Jack Katz, Feb. 10, 1999, pp. 1-32, 22 Filled: 15, 1999 regarding civil action entitled, Playtex Products, Inc. and 22 File Jun. 15, Sun Pharmaceuticals Corporation vs. Schering-Plough Related U.S. Application Data Healthcare Products, Inc., Case No. 98–482-RPM, United States District Court, Middle District of Delaware. 63 Continuation of application No. 09/217,170, Dec. 21, 1998, First Amended Complaint, IPA v Schering-Plough et al., which is a continuation of application No. 09/024,458, Feb. Civil Action No. 98–482 (RRM), Jan. 22, 1999, 14 pages. ship, alengageplain E. Defendants' Answer & Counterclaims to First Amended ation of application N. Soss 64.
    [Show full text]
  • Jan 19, 2009 Listing of Generic, Non
    http://www.medword.com/uspa.html Jan 19, 2009 Listing of generic, non-prescription, prescription, and OTC (over-the-counter) p harmaceuticals A-200 Gel Concentrate A-200 Shampoo Concentrate A-25 A-Cillin A-Fil A-Hydrocort A-methaPred A-Phedrin A-Spas S/L A Plus A.C. & C. A.P.L. A.R.M. Allergy Relief A.R.M. Maximum Strength Caplets A/B Otic A/Fish Oil A/T/S abacavir abarelix-depot-F abarelix-depot-M Abbokinase Abbokinase Open-Cath Abelcet Abenol Abitrate Absorbine Athletes Foot Absorbine Jock Itch Absorbine Jr. Antifungal AC acarbose Accolate Accupep HPF Accupril Accuretic Accutane Accutane Roche acebutolol Acel-Imune Acellular DTP Aceon Acet-2 Acet-3 Acet Codeine 30 Acet Codeine 60 Aceta Aceta Elixir Aceta Tablets acetaminophen acetaminophen-butalbital acetaminophen-caffeine acetaminophen-chlorpheniramine acetaminophen-codeine acetaminophen-dextromethorphan acetaminophen-diphenhydramine acetaminophen-hydrocodone acetaminophen-oxycodone acetaminophen-phenyltoloxamine acetaminophen-propoxyphene acetaminophen-propoxyphene hydrochloride acetaminophen-propoxyphene napsylate acetaminophen-pseudoephedrine acetazolam acetazolamide Acetest acetic acid Acetocot acetohexamide acetophenazine Acetoxyl 10 Gel Acetoxyl 2.5 Gel Acetoxyl 20 Gel Acetoxyl 5 Gel acetylsalicylic acid Achromycin Achromycin V aciclovir Acid Control Acid Phos Fluor Rinse Acilac Aciphex acitretin Aclophen Aclovate Acne-10 Lotion Acne-5 Lotion Acne-Aid Aqua Gel Acne-Aid Gel Acne-Aid Vanishing Cream Acne Aid 10 Cream Acne Lotion 10 Acne Prone Skin Sunscreen Acne Wash Acno Acnomel
    [Show full text]
  • Salicylate UV-Filters in Sunscreen Formulations Compromise the Preservative System Efficacy Against Pseudomonas Aeruginosa and Burkholderia Cepacia
    cosmetics Article Salicylate UV-Filters in Sunscreen Formulations Compromise the Preservative System Efficacy against Pseudomonas aeruginosa and Burkholderia cepacia Noa Ziklo, Inbal Tzafrir, Regina Shulkin and Paul Salama * Innovation department, Sharon Laboratories Ltd., Odem St. Industrial zone Ad-Halom, Ashdod 7898800, Israel; [email protected] (N.Z.); [email protected] (I.T.); [email protected] (R.S.) * Correspondence: [email protected]; Tel.: +972-54-2166476 Received: 15 July 2020; Accepted: 1 August 2020; Published: 3 August 2020 Abstract: Contamination of personal-care products are a serious health concern and therefore, preservative solutions are necessary for the costumers’ safety. High sun protection factor (SPF) sunscreen formulations are known to be difficult to preserve, due to their high ratio of organic phase containing the UV-filters. Salicylate esters such as octyl salicylate (OS) and homosalate (HS) are among the most common UV-filters currently used in the market, and can undergo hydrolysis by esterase molecules produced by contaminant microorganisms. The hydrolysis product, salicylic acid (SA) can be assimilated by certain bacteria that contain the chorismate pathway, in which its final product is pyochelin, an iron-chelating siderophore. Here, we show that OS and HS can compromise the preservative efficacy against two pathogenic important bacteria, Pseudomonas aeruginosa and Burkholderia cepacia. Challenge tests of formulations containing the UV-filters demonstrated that only bacteria with the chorismate pathway failed to be eradicated by the preservation system. mRNA expression levels of the bacterial pchD gene, which metabolizes SA to produce pyochelin, indicate a significant increase that was in correlation with increasing concentrations of both OS and HS.
    [Show full text]